The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
June 5th 2023
Powered by deep learning technology, Sonic DL reportedly facilitates the acquisition of cardiac magnetic resonance imaging (MRI) scans at 12 times the speed of conventional MRI systems.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy ApplicationOctober 20th 2022
For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
Recognizing the Role of Enterprise Imaging in Handling and Protecting Sensitive Patient Information
While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.
Mammography News: FDA Says National Breast Density Notification Rule May Be Published in Late 2022 or Early 2023October 18th 2022
In a recent letter to U.S. Rep. Rosa DeLauro (D-CT), the Food and Drug Administration (FDA) said a final rule on amendments to the Mammography Quality Standards Act (MQSA), including an oft-delayed national standard for breast density notification in mammography reporting, may be published in the next couple of months.
Could Brain MRI Screening be Beneficial for Patients with Inflammatory Breast Cancer?October 11th 2022
While current consensus guidelines do not recommend the use of brain MRI screening in patients with breast cancer, a new study shows significantly elevated risks for the development of central nervous system metastasis in patients with inflammatory breast cancer.
Adjunctive AI Software for Brain MRI Gets FDA Clearance for Assessing High-Grade GliomasOctober 10th 2022
Incorporating artificial intelligence (AI)-based technology, Neosoma HGG reportedly demonstrated a 95.5 percent accuracy rate in measuring brain tumor volume on brain magnetic resonance imaging (MRI) scans at various points during the treatment of patients with high-grade gliomas.
Digital Breast Tomosynthesis and Breast Density: What a New Study RevealsOctober 6th 2022
In a large study of nearly 100,000 women, researchers found that the combination of digital breast tomosynthesis (DBT) and synthesized mammography had more than triple the detection rate for invasive breast cancer in extremely dense breasts in comparison to digital mammography alone.
Reinventing Radiology Reports in the Age of Value-Based CareOctober 4th 2022
In a thorough review of the literature, these authors discuss current approaches and emerging initiatives to increase the understanding of radiology reports by referring physicians as well as patients.
Study Finds No Benefit to MRI Screening in Women with High-Risk Breast LesionsOctober 3rd 2022
In a study involving nearly 700 patients with atypical ductal or lobular hyperplasia, or lobular carcinoma in situ, researchers found no difference in four-year breast cancer detection rates between women who had screening mammography and breast magnetic resonance imaging (MRI), and women who only had mammography screening.
Prospective MRI Study Reveals Impact of Opioid Exposure on the Fetal BrainSeptember 30th 2022
Researchers found that in utero opioid exposure resulted in seven out of 14 2D biometric measurements of the fetal brain being smaller on magnetic resonance imaging (MRI) scans in comparison to fetuses without opioid exposure.
MRI Deep Learning Software from GE Healthcare Gets Expanded FDA ClearanceSeptember 29th 2022
AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.
A Closer Look at Ultrasound and MRI Alternatives for Head and Neck ImagingSeptember 29th 2022
In light of recent shortages of iodinated contrast media, researchers from Australia suggest in a new publication that ultrasound and magnetic resonance imaging (MRI) can be viable first-line imaging options for a number of non-urgent presentations of the head and neck.
What a New Meta-Analysis Reveals About Breast Density, Mammography and MRI ScreeningSeptember 28th 2022
Assessing data from 386,590 women, researchers noted that women with extremely dense breast tissue have more than double the risk for breast cancer in comparison to women with average breast density and nearly four times the risk of women with extremely fatty breast tissue.
FDA Approves New MRI Contrast Agent GadopiclenolSeptember 22nd 2022
Requiring only half of the gadolinium dose of current non-specific gadolinium-based contrast agents (GBCAs), gadopiclenol can be utilized with magnetic resonance imaging (MRI) to help detect lesions with abnormal vascularity in the central nervous system and other areas of the body.
Study Shows Adjunctive Benefit of Pre-Biopsy MRI for Diagnosing Prostate CancerSeptember 20th 2022
Emerging research suggests that combining pre-biopsy magnetic resonance imaging (MRI) with prostate-specific antigen (PSA) testing more than triples the specificity rate for detecting clinically significant prostate cancer in comparison to sole reliance on a PSA level greater than or equal to 4 ng/mL.
Post-Vaccine Axillary Lymphadenopathy: What a New Chest MRI Study RevealsSeptember 19th 2022
In a new study looking at the development of axillary lymphadenopathy after a second dose of COVID-19 vaccination, researchers found that those who had the Moderna COVID-19 vaccine were 21 percent more likely to have the post-vaccine side effect in comparison to those who had the Pfizer-BioNtech COVID-19 vaccine.
Managing Incidentalomas in Radiology: Embracing Challenges as OpportunitiesSeptember 12th 2022
Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.
Could the New Stratus Imaging PACS Viewer Help Streamline Radiology Workflows?September 9th 2022
Offering a variety of features to enhance efficiency, bolster security and reduce IT overhead, the cloud-native SaaS platform may help radiologists minimize workflow issues that can impede practices with high imaging volume.
Surveillance MRI Study Shows Link Between Background Parenchymal Enhancement and Higher Risk of Second Breast CancerAugust 30th 2022
Mild, moderate, or marked background parenchymal enhancement on surveillance magnetic resonance imaging (MRI) reportedly doubles the risk of second breast cancer in women who have had surgery for primary breast cancer.